Just wanted to say β for anyone reading this GLP-1 and gluconeoge thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. πͺ
Want to share my personal experience related to GLP-1 and gluconeogenesis since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 250 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 6 months later: I am down 50 lbs, my labs have normalized, and I am off 2 of my 3 medications. The GLP-1 and gluconeoge aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
Clinical perspective on GLP-1 and gluconeogenesis what worked:
I have managed ~150 patients on GLP-1 therapy and this topic comes up frequently. What the data shows β and what I see in practice β is that proper titration prevents most adverse events.
For this specific question, I would recommend: reviewing the relevant clinical guidelines.
Relevant to GLP-1 and gluconeogenesis β here is my latest bloodwork comparison:
Key improvements: A1C 7.2% β 5.3%, triglycerides 243 β 113 mg/dL, hsCRP 6.0 β 1.3 mg/L. All on tirzepatide for 11 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.